Liver Tumor Clinic

Using a multidisciplinary approach to treat cancer is something for which Emory is well known. But many may not know there is a multidisciplinary team right here at the Emory Transplant Center with the mission of improving survival rates for liver cancer. Hepatocellular carcinoma (HCC) is the most common liver cancer in the U.S. and incidence is rising. For patients with early-stage primary HCC, liver transplantation may be their best chance of survival.

Emory’s Liver Tumor Clinic, the only program of its kind in the state, was first started in May 2012.  The clinic consists of a team of transplant hepatologists, liver transplant surgeons, interventional radiologists, midlevel professionals, palliative oncologists, medical oncologists, nurse coordinators, pharmacists, and others who help personalize treatments depending on patients’ needs. Almost all of the patients in the clinic have HCC originating in the liver, but a few have cholangiocarcinoma (bile duct cancer) that has developed in ducts within the liver. The team discusses cases and determines treatment plans, which can involve hepatobiliary surgery, chemotherapy, transplantation, and/or palliative therapy.

The multidisciplinary team discusses patients with liver, pancreatic, or biliary tumors. The goal is to design comprehensive treatment plans with input from multiple specialties and to provide learning opportunities for practitioners so that they can provide the highest-quality care. Moreover, findings from this conference are the source of ongoing outcomes research and NIH-funded clinical trials.

We welcome participation and input from our community of referring physicians. Please print and fill out the required HIPAA compliance forms below and fax them to
404-712-2999.